Randhawa Simrat Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
2
Insider Sells Sum
$7.38M

Insider Activity of Randhawa Simrat

According to the SEC Form 4 filings, Randhawa Simrat, being in a position of

  1. EVP, Head of R&D at Dianthus Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 280022 shares for $15M,
    over all time since 2025-11-13, has bought 0 shares, and sold 280022 shares for $15M.

Biography of Randhawa Simrat

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$15,001,1235100

Comparison of Insiders on Amount of Buys and Sells

2026-09-01SaleDianthus Therapeutics, Inc.
DNTH
EVP, Head of R&D
23,124
0.0413%
$106.41$2.46M-17.94%
2026-06-01SaleDianthus Therapeutics, Inc.
DNTH
EVP, Head of R&D
26,530
0.0644%
$90.62$2.4M+7.45%
2026-03-12SaleDianthus Therapeutics, Inc.
DNTH
EVP, Head of R&D
33,830
0.0948%
$81.48$2.76M+11.37%
2025-11-14SaleDianthus Therapeutics, Inc.
DNTH
EVP, Head of R&D
109,031
0.3235%
$38.14$4.16M+105.13%
2025-11-13SaleDianthus Therapeutics, Inc.
DNTH
EVP, Head of R&D
87,507
0.2506%
$36.81$3.22M+135.69%
Total: 5
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.